share_log

In-Depth Examination Of 6 Analyst Recommendations For Evolent Health

In-Depth Examination Of 6 Analyst Recommendations For Evolent Health

深入研究分析師對Evolent Health的6條建議
Benzinga ·  04/23 04:02
Evolent Health (NYSE:EVH) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在過去的三個月中，有6位分析師對Evolent Health（紐約證券交易所代碼：EVH）進行了分析，揭示了從看漲到看跌的不同觀點。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表簡要介紹了他們最近的評級，展示了過去30天情緒的演變，並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for Evolent Health, revealing an average target of $44.0, a high estimate of $52.00, and a low estimate of $38.00. A 3.3% drop is evident in the current average compared to the previous average price target of $45.50.
分析師已經爲Evolent Health設定了12個月的目標股價，顯示平均目標股價爲44.0美元，最高估計爲52.00美元，低估值爲38.00美元。與之前的平均目標價45.50美元相比，當前的平均價格下降了3.3％。
Investigating Analyst Ratings: An Elaborate Study
調查分析師評級：一項詳盡的研究
The perception of Evolent Health...
通過分析師...
登入免費觀看全文
登入/註冊

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論